Belgium Wound Care Management Medical Equipment Industry Report

Published by: Global Markets Direct

Published: May. 2, 2008 - 217 Pages

Table of Contents

1 Table Of Contents

1.1 List Of Tables

1.2 List of Figures

2 Introduction

2.1 What Is This Report About?

2.2 Definitions

2.2.1 Wound Care Management

3 Healthcare Sector Review

3.1 Healthcare Expenditure

3.2 Healthcare Infrastructure

3.2.1 Healthcare Personnel Data

3.2.2 Healthcare Facilities Data

3.3 Healthcare Policy

4 Wound Care Management in Belgium

4.1 Wound Care Management Overall Revenues (2000-2012)

4.2 Wound Care Management Overall Volume (2000-2012)

4.3 Wound Care Management Overall Company Shares (2005-2006)

5 Wound Closure Devices in Belgium

5.1 Wound Closure Devices Overall Revenues (2000-2012)

5.1.1 Skin Closure Devices Overall Revenues (2000-2012)

5.1.2 Hemostats Overall Revenues (2000-2012)

5.1.3 Tissue Sealants Overall Revenues (2000-2012)

5.2 Wound Closure Devices Overall Volume (2000-2012)

5.2.1 Skin Closure Devices Overall Volume (2000-2012)

5.2.2 Tissue Sealants Overall Volume (2000-2012)

5.2.3 Hemostats Overall Volume (2000-2012)

5.3 Wound Closure Devices Average Price (2000-2012)

5.3.1 Hemostats Average Price (2000-2012)

5.3.2 Tissue Sealants Average Price (2000-2012)

5.3.3 Skin Closure Devices Average Price (2000-2012)

5.4 Wound Closure Devices Distribution Share (2005-2006)

5.5 Wound Closure Devices Company Share (2005-2006)

6 Ostomy in Belgium

6.1 Ostomy Overall Revenue (2000-2012)

6.2 Ostomy Overall Volume (2000-2012)

6.3 Ostomy Average Price (2000-2012)

6.4 Ostomy Distribution Share (2005-2006)

6.5 Ostomy Company Share (2005-2006)

7 Advanced Wound Management in Belgium

7.1 Advanced Wound Management Overall Revenue (2000-2012)

7.2 Advanced Wound Management Overall Volume (2000-2012)

7.3 Advanced Wound Management Average Price (2000-2012)

7.4 Advanced Wound Management Distribution Share (2005-2006)

7.5 Advanced Wound Management Company Share (2005-2006)

8 Traditional Wound Management

8.1 Traditional Wound Management Overall Revenue (2000-2012)

8.2 Traditional Wound Management Overall Volume (2000-2012)

8.3 Traditional Wound Management Average Price (2000-2012)

8.4 Traditional Wound Management Distribution Share (2005-2006)

8.5 Traditional Wound Management Company Share (2005-2006)

9 Compression Therapy in Belgium

9.1 Compression Therapy Overall Revenue (2000-2012)

9.2 Compression Therapy Overall Volume (2000-2012)

9.3 Compression Therapy Average Price (2000-2012)

9.4 Compression Therapy Distribution Share (2005-2006)

9.5 Compression Therapy Company Share (2005-2006)

10 Baxter International Company Profile

10.1 Company Overview

10.2 Business Overview

10.2.1 BioScience

10.2.2 Medication Delivery

10.2.3 Renal

10.2.4 Products

10.2.5 History

10.3 Value Chain Analysis

10.3.1 Manufacturing

10.3.2 Product Development

10.3.3 Sales and Marketing

10.4 SWOT Analysis

10.4.1 Baxter International Inc. Strengths

10.4.2 Baxter International Inc. Weaknesses

10.4.3 Baxter International Inc. Opportunities

10.4.4 Baxter International Inc. Threats

10.5 Financial and Operational Review

10.6 Locations And Subsidiaries

10.7 Financial Deals Landscape

10.7.1 Baiyunshan And Baxter Form A Joint Venture In China

10.7.2 Baxter Signs Licensing Agreement With Intercytex And Spinal Restoration

10.7.3 Baxter Sells Transfusion Therapies Business to Texas Pacific and Maverick Capital

10.7.4 B. Braun Acquires Renal Therapy Business Of Baxter

10.7.5 Innovata signs a license agreement with Baxter International

10.7.6 Kuros Biosurgery Signs An Agreement With Baxter International

10.7.7 Gambro Signs An Agreement With Baxter

10.7.8 Baxter Healthcare And Gambro Enter Into An Agreement

10.7.9 Baxter and Cerus Enter Into Agreement With BioOne for Commercialization Of INTERCEPT Blood System

10.7.10 Baxter International And Kaketsuken Enter Into Agreement

10.7.11 Baxter To Acquire 40% Stake In Shanghai Baxter From Worldbest Treeful

10.8 Recent Developments

10.8.1 Jan 24, 2008: Baxter Achieves Record Sales and Earnings for Full-Year 2007

10.8.2 Dec 18, 2007: Baxter Elects CFO

10.8.3 Nov 13, 2007: Baxter Declares Quarterly Dividend

10.8.4 Aug 01, 2007: Baxter Elects New Board Director

10.8.5 Jul 31, 2007: Baxter Announces Quarterly Dividend

10.8.6 Mar 13, 2007: Baxter Declares Additional Share Repurchase Authorization

10.8.7 Feb 13, 2007: Baxter Announces Quarterly Dividend

10.8.8 Nov 28, 2006: Baxter Announces Annual Dividend

10.8.9 Sep 14, 2006: Baxter Appoints President, Baxter Latin America

10.9 Baxter International Inc. Pipeline Products

10.9.1 Next-Generation Home Hemodialysis Machine

11 The HARTMANN GROUP Company Profile

11.1 Company Overview

11.2 Business Overview

11.2.1 Incontinence Management

11.2.2 Operating Theater Management

11.2.3 Other GROUP Activities

11.2.4 Wound Management

11.2.5 Products

11.2.6 History

11.3 Value Chain Analysis

11.3.1 Manufacturing

11.3.2 Product Development

11.3.3 Sales and Marketing

11.4 SWOT Analysis

11.4.1 HARTMANN GROUP Strengths

11.4.2 HARTMANN GROUP Weaknesses

11.4.3 HARTMANN GROUP Opportunities

11.4.4 HARTMANN GROUP Threats

11.5 Financial and Operational Review

11.6 Locations And Subsidiaries

11.7 Recent Developments

11.7.1 Mar 17, 2008: Hartmann Declares 2007 Results

11.7.2 Jan 29, 2008: HARTMANN Establishes New Subsidiary In Siberia

11.7.3 Jan 11, 2008: HARTMANN Launches New Subsidiary In Ulm

11.7.4 Aug 10, 2007: Hartmann Reports H1 2007 Results

12 Coloplast A/S Company Profile

12.1 Company Overview

12.2 Business Overview

12.2.1 Medical Care

12.2.2 Major Products and Services

12.2.3 History

12.3 Value Chain Analysis

12.3.1 Manufacturing

12.3.2 Product Development

12.3.3 Sales and Marketing

12.4 SWOT Analysis

12.4.1 Coloplast A/S Strengths

12.4.2 Coloplast A/S Weaknesses

12.4.3 Coloplast A/S Opportunities

12.4.4 Coloplast A/S Threats

12.5 Financial and Operational Review

12.5.1 Financial Statements

12.5.2 Financial Ratios

12.5.3 Share Holding Structure

12.6 Locations And Subsidiaries

12.7 Financial Deals Landscape

12.7.1 Coloplast Sells Brachytherapy Business To Core Oncology

12.7.2 Coloplast Signs Distribution Agreement With Carbon Medical Technologies

12.7.3 Granville Baird Capital Partners Advisors Acquires Coloplast’s Business Unit

12.7.4 McKesson Corporation Acquires Sterling Medical Services

12.7.5 Coloplast Acquires Surgical Urology And Clinical And Consumer Healthcare Business Segments Of Mentor

12.8 Recent Developments

12.8.1 Apr 07, 2008: Coloplast Plans To Invest EUR100 Million In Hungary

12.8.2 Feb 19, 2008: Coloplast Declares Q1 Fiscal 2008 Results

12.8.3 Nov 20, 2007: Coloplast Declares Fiscal 2007 Results

12.8.4 Aug 16, 2007: Coloplast Declares Nine Months Ended 2007 Results

12.8.5 May 15, 2007: Colplast Declares H1 2007 Results

12.8.6 Feb 08, 2007: Coloplast Declares Q1 Fiscal 2007 Results

12.8.7 Dec 13, 2006: Coloplast Appoints New Chairman

12.8.8 Nov 15, 2006: Coloplast Declares Fiscal 2006 Results

13 ConvaTec Company Profile

13.1 Company Overview

13.2 Business Overview

13.2.1 Major Products and Services

13.2.2 History

13.3 Locations And Subsidiaries

13.4 Recent Developments

13.4.1 Jan 22, 2008: Vivolution Acquires Patent From BMS

13.4.2 Nov 12, 2007: Alltracel Signs Development Agreement With ConvaTec

14 Ethicon, Inc. Company Profile

14.1 Company Overview

14.2 Business Overview

14.2.1 Products

14.3 Locations And Subsidiaries

14.4 Financial Deals Landscape

14.4.1 Edwards Lifesciences Acquires CardioVations Product Line From ETHICON

14.4.2 Musculoskeletal Transplant Signs Marketing Agreement With ETHICON

14.4.3 ETHICON Acquires Vascular Control Systems

14.4.4 Datascope Acquires Endoscopic Vessel Harvesting Business From ETHICON

15 Regulation System

15.1 Medical Equipment Approval Process

15.1.1 Classification

15.1.2 Conformity Assessment Process

15.2 Notification Fee

16 Pricing and Reimbursement

16.1 Reimbursement Policies

17 Distribution Structure

18 APPENDIX

18.1 Global Markets Direct Research Methodology

18.2 Coverage

18.3 Secondary Research

18.4 Primary Research

18.5 Models

18.6 Forecasts

18.7 Expert Panels

18.8 Currency Conversion

18.9 Contact Us

18.10 Disclaimer

1.1 List Of Tables

Table 1: Hospitals and Hospital Beds in Belgium, 2005

Table 2: Number of Doctors by Specialty in Belgium, 2003-2007

Table 3: Number of Hospital Wards by Specialty in Belgium, 2003-2007

Table 4: Wound Care Management, Belgium, Overall Revenues ($ mn), 2000-2012

Table 5: Wound Care Management, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Table 6: Wound Care Management, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Table 7: Wound Care Management, Belgium, Category Revenues ($ mn), 2000-2012

Table 8: Wound Care Management, Belgium, Category Revenues ($ mn), Historic, 2000-2007

Table 9: Wound Care Management, Belgium, Category Revenues ($ mn), Forecast, 2007-2012

Table 10: Wound Care Management, Belgium, Category Volume (Units), 2000-2012

Table 11: Wound Care Management, Belgium, Category Volume (Units), Historic, 2000-2007

Table 12: Wound Care Management, Belgium, Category Volume (Units), Forecast, 2007-2012

Table 13: Wound Care Management, Belgium, Company Share by Revenue ($ mn), 2005-2006

Table 14: Wound Closure Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Table 15: Wound Closure Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Table 16: Wound Closure Devices, Belgium, Revenue by Segment ($ mn), Historic, 2000-2007

Table 17: Wound Closure Devices, Belgium, Revenue by Segment ($ mn), Forecast, 2007-2012

Table 18: Skin Closure Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Table 19: Skin Closure Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Table 20: Hemostats, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Table 21: Hemostats, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Table 22: Tissue Sealants, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Table 23: Tissue Sealants, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Table 24: Wound Closure Devices, Belgium, Overall Volume (Units), Historic, 2000-2007

Table 25: Wound Closure Devices, Belgium, Overall Volume (Units), Forecast, 2007-2012

Table 26: Skin Closure Devices, Belgium, Overall Volume (Units), Historic, 2000-2007

Table 27: Skin Closure Devices, Belgium, Overall Volume (Units), Forecast, 2007-2012

Table 28: Tissue Sealants, Belgium, Overall Volume (Units), Historic, 2000-2007

Table 29: Tissue Sealants, Belgium, Overall Volume (Units), Forecast, 2007-2012

Table 30: Hemostats, Belgium, Overall Volume (Units), Historic, 2000-2007

Table 31: Hemostats, Belgium, Overall Volume (Units), Forecast, 2007-2012

Table 32: Hemostats, Belgium, Average Price ($), Historic, 2000-2007

Table 33: Hemostats, Belgium, Average Price ($), Forecast, 2007-2012

Table 34: Tissue Sealants, Belgium, Average Price ($), Historic, 2000-2007

Table 35: Tissue Sealants, Belgium, Average Price ($), Forecast, 2007-2012

Table 36: Skin Closure Devices, Belgium, Average Price ($), Historic, 2000-2007

Table 37: Skin Closure Devices, Belgium, Average Price ($), Forecast, 2007-2012

Table 38: Wound Closure Devices, Belgium, Distribution Share by Revenue ($ mn), 2005-2006

Table 39: Wound Closure Devices, Belgium, Company Share by Revenue ($ mn), 2005-2006

Table 40: Ostomy, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Table 41: Ostomy, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Table 42: Ostomy, Belgium, Overall Volume (Units), Historic, 2000-2007

Table 43: Ostomy, Belgium, Overall Volume (Units), Forecast, 2007-2012

Table 44: Ostomy, Belgium, Average Price ($), Historic, 2000-2007

Table 45: Ostomy, Belgium, Average Price ($), Forecast, 2007-2012

Table 46: Ostomy, Belgium, Distribution Share by Revenue ($ mn), 2005-2006

Table 47: Ostomy, Belgium, Company Share by Revenue ($ mn), 2005-2006

Table 48: Advanced Wound Management, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Table 49: Advanced Wound Management, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Table 50: Advanced Wound Management, Belgium, Overall Volume (Units), Historic, 2000-2007

Table 51: Advanced Wound Management, Belgium, Overall Volume (Units), Forecast, 2007-2012

Table 52: Advanced Wound Management, Belgium, Average Price ($), Historic, 2000-2007

Table 53: Advanced Wound Management, Belgium, Average Price ($), Forecast, 2007-2012

Table 54: Advanced Wound Management, Belgium, Distribution Share by Revenue ($ mn), 2005-2006

Table 55: Advanced Wound Management, Belgium, Company Share by Revenue ($ mn), 2005-2006

Table 56: Traditional Wound Management, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Table 57: Traditional Wound Management, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Table 58: Traditional Wound Management, Belgium, Overall Volume (Units), Historic, 2000-2007

Table 59: Traditional Wound Management, Belgium, Overall Volume (Units), Forecast, 2007-2012

Table 60: Traditional Wound Management, Belgium, Average Price ($), Historic, 2000-2007

Table 61: Traditional Wound Management, Belgium, Average Price ($), Forecast, 2007-2012

Table 62: Traditional Wound Management, Belgium, Distribution Share by Revenue ($ mn), 2005-2006

Table 63: Traditional Wound Management, Belgium, Company Share by Revenue ($ mn), 2005-2006

Table 64: Compression Therapy, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Table 65: Compression Therapy, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Table 66: Compression Therapy, Belgium, Overall Volume (Units), Historic, 2000-2007

Table 67: Compression Therapy, Belgium, Overall Volume (Units), Forecast, 2007-2012

Table 68: Compression Therapy, Belgium, Average Price ($), Historic, 2000-2007

Table 69: Compression Therapy, Belgium, Average Price ($), Forecast, 2007-2012

Table 70: Compression Therapy, Belgium, Distribution Share by Revenue ($ mn), 2005-2006

Table 71: Compression Therapy, Belgium, Company Share by Revenue ($ mn), 2005-2006

Table 72: Baxter International Inc., SWOT Analysis, 2006

Table 73: Baxter International Inc., Financial Statements, USD Million, 2002-2006

Table 74: Baxter International Inc., Financial Ratios, USD Million, 2002-2006

Table 75: Baxter International Inc., Other Locations

Table 76: Baxter International Inc., Subsidiaries

Table 77: HARTMANN GROUP, SWOT Analysis, 2006

Table 78: HARTMANN GROUP, Financial Statements, Euro Thousand, 2002-2006

Table 79: HARTMANN GROUP, Financial Ratios, Euro Thousand, 2002-2006

Table 80: HARTMANN GROUP, Subsidiaries

Table 81: Coloplast A/S, SWOT Analysis, 2007

Table 82: Coloplast A/S, Financial Statements, DKK Million, 2003-2007

Table 83: Coloplast A/S, Financial Ratios, DKK Million, 2003-2007

Table 84: Coloplast A/S, Share Holding Structure

Table 85: Coloplast A/S, Other Locations

Table 86: Coloplast A/S, Subsidiaries

Table 87: Coloplast A/S, Subsidiaries(Contd.)

Table 88: ConvaTec, Other Locations

Table 89: Ethicon, Inc., Other Locations

Table 90: Ethicon, Inc., Subsidiaries

Table 91: Medical Equipment Notification Fee in Belgium, 2007

Table 92: Currency Conversion from USD to Local Currency at 2007 Constant Rate

1.1 List of Figures

Figure 1: Total Healthcare Expenditure in Belgium, 2000 - 2006

Figure 2: Structure of Healthcare System in Belgium, 2007

Figure 3: Wound Care Management, Belgium, Overall Revenues ($ mn), 2000-2012

Figure 4: Wound Care Management, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Figure 5: Wound Care Management, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 6: Wound Care Management, Belgium, Category Revenues ($ mn), 2000-2012

Figure 7: Wound Care Management, Belgium, Category Revenues ($ mn), Historic, 2000-2007

Figure 8: Wound Care Management, Belgium, Category Revenues ($ mn), Forecast, 2007-2012

Figure 9: Wound Care Management, Belgium, Category Volume (Units), 2000-2012

Figure 10: Wound Care Management, Belgium, Category Volume (Units), Historic, 2000-2007

Figure 11: Wound Care Management, Belgium, Category Volume (Units), Forecast, 2007-2012

Figure 12: Wound Care Management, Belgium, Company Share (%), 2006

Figure 13: Wound Closure Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Figure 14: Wound Closure Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 15: Wound Closure Devices, Belgium, Revenue by Segment ($ mn), Historic, 2000-2007

Figure 16: Wound Closure Devices, Belgium, Revenue by Segment ($ mn), Forecast, 2007-2012

Figure 17: Skin Closure Devices, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Figure 18: Skin Closure Devices, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 19: Hemostats, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Figure 20: Hemostats, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 21: Tissue Sealants, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Figure 22: Tissue Sealants, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 23: Wound Closure Devices, Belgium, Overall Volume (Units), Historic, 2000-2007

Figure 24: Wound Closure Devices, Belgium, Overall Volume (Units), Forecast, 2007-2012

Figure 25: Skin Closure Devices, Belgium, Overall Volume (Units), Historic, 2000-2007

Figure 26: Skin Closure Devices, Belgium, Overall Volume (Units), Forecast, 2007-2012

Figure 27: Tissue Sealants, Belgium, Overall Volume (Units), Historic, 2000-2007

Figure 28: Tissue Sealants, Belgium, Overall Volume (Units), Forecast, 2007-2012

Figure 29: Hemostats, Belgium, Overall Volume (Units), Historic, 2000-2007

Figure 30: Hemostats, Belgium, Overall Volume (Units), Forecast, 2007-2012

Figure 31: Hemostats, Belgium, Average Price ($), Historic, 2000-2007

Figure 32: Hemostats, Belgium, Average Price ($), Forecast, 2007-2012

Figure 33: Tissue Sealants, Belgium, Average Price ($), Historic, 2000-2007

Figure 34: Tissue Sealants, Belgium, Average Price ($), Forecast, 2007-2012

Figure 35: Skin Closure Devices, Belgium, Average Price ($), Historic, 2000-2007

Figure 36: Skin Closure Devices, Belgium, Average Price ($), Forecast, 2007-2012

Figure 37: Wound Closure Devices, Belgium, Distribution Share (%), 2006

Figure 38: Wound Closure Devices, Belgium, Company Share (%), 2006

Figure 39: Ostomy, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Figure 40: Ostomy, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 41: Ostomy, Belgium, Overall Volume (Units), Historic, 2000-2007

Figure 42: Ostomy, Belgium, Overall Volume (Units), Forecast, 2007-2012

Figure 43: Ostomy, Belgium, Average Price ($), Historic, 2000-2007

Figure 44: Ostomy, Belgium, Average Price ($), Forecast, 2007-2012

Figure 45: Ostomy, Belgium, Company Share (%), 2006

Figure 46: Advanced Wound Management, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Figure 47: Advanced Wound Management, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 48: Advanced Wound Management, Belgium, Overall Volume (Units), Historic, 2000-2007

Figure 49: Advanced Wound Management, Belgium, Overall Volume (Units), Forecast, 2007-2012

Figure 50: Advanced Wound Management, Belgium, Average Price ($), Historic, 2000-2007

Figure 51: Advanced Wound Management, Belgium, Average Price ($), Forecast, 2007-2012

Figure 52: Advanced Wound Management, Belgium, Distribution Share (%), 2006

Figure 53: Advanced Wound Management, Belgium, Company Share (%), 2006

Figure 54: Traditional Wound Management, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Figure 55: Traditional Wound Management, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 56: Traditional Wound Management, Belgium, Overall Volume (Units), Historic, 2000-2007

Figure 57: Traditional Wound Management, Belgium, Overall Volume (Units), Forecast, 2007-2012

Figure 58: Traditional Wound Management, Belgium, Average Price ($), Historic, 2000-2007

Figure 59: Traditional Wound Management, Belgium, Average Price ($), Forecast, 2007-2012

Figure 60: Traditional Wound Management, Belgium, Distribution Share (%), 2006

Figure 61: Traditional Wound Management, Belgium, Company Share (%), 2006

Figure 62: Compression Therapy, Belgium, Overall Revenues ($ mn), Historic, 2000-2007

Figure 63: Compression Therapy, Belgium, Overall Revenues ($ mn), Forecast, 2007-2012

Figure 64: Compression Therapy, Belgium, Overall Volume (Units), Historic, 2000-2007

Figure 65: Compression Therapy, Belgium, Overall Volume (Units), Forecast, 2007-2012

Figure 66: Compression Therapy, Belgium, Average Price ($), Historic, 2000-2007

Figure 67: Compression Therapy, Belgium, Average Price ($), Forecast, 2007-2012

Figure 68: Compression Therapy, Belgium, Distribution Share (%), 2006

Figure 69: Compression Therapy, Belgium, Company Share (%), 2006

Figure 70: Baxter International Inc., Value Chain Analysis

Figure 71: HARTMANN GROUP, Value Chain Analysis

Figure 72: Coloplast A/S, Value Chain Analysis

Figure 73: Flowchart for Classification of Non-invasive Devices in Belgium, 2007

Figure 74: Flowchart for Classification of Invasive Devices in Belgium, 2007

Figure 75: Flowchart for Classification of Invasive Devices in Belgium, 2007

Figure 76: Flowchart for Classification of Invasive Devices in Belgium, 2007

Figure 77: Flowchart for Classification of Invasive Devices in Belgium, 2007

Figure 78: Flowchart for Classification of Active Devices in Belgium, 2007

Figure 79: Flowchart for Classification of Active Devices in Belgium, 2007

Figure 80: Flowchart for Classification of Devices except Non-invasive, Invasive and Active Devices in Belgium, 2007

Figure 81: Conformity Assessment of Class-I Medical Devices in Belgium, 2007

Figure 82: Conformity Assessment of Class-IIa Medical Devices in Belgium, 2007

Figure 83: Conformity Assessment of Class-IIb Medical Devices in Belgium, 2007

Figure 84: Conformity Assessment of Class-III Medical Devices in Belgium, 2007

Figure 85: Global Markets Direct Methodology

Abstract

• The report provides sector information broken down into detailed categories and segments in country.
• Total revenues, products sold, end users, and average pricing.
• Market shares of all the key competitors.
• Key pipeline products that are set to shape the market, broken down by sector.
• Information on the top medical equipment companies in the sector in the country covering business description, strategic analysis, and financial information.
• Healthcare structure, regulatory environment, approval process, pricing trends and reimbursement.
• Product and brand updates, strategy changes, R&D projects, corporate expansions and contractions and regulatory changes.
• Key mergers and acquisitions, partnerships, private equity investments and IPOs.
• Customer, hospitals and physicians data.

• Gain a strong understanding of the industry at a global level, with break downs for the country
• Evaluate and compare the attractiveness of the market in the country.
• Identify growth segments and opportunities in each industry sector within the country.
• Evaluate the pipeline of key products that will change the sector, and identify threats and opportunities before the products are launched in the country.
• Analyze the competitiveness of the market in the country and identify hotspots.
• Develop strategies based on the latest product, brand, expansion and research and development news in the country.
• Do deals with an understanding of how competitors are financed, and the mergers and partnerships that have shaped the market in the country.
• Identify and analyze the strengths and weaknesses of the industry incumbents in the country.

About MarketResearch.com
MarketResearch.com is an online aggregator selling over 160,000 market research reports, company profiles and country profiles from over 600 research firms. Our reports will provide you with the critical business and competitive intelligence you need for strategic planning and marketing research. Coverage includes the US, UK, Europe, Asia and global markets.